Friday, July 10, 2026

Drug profile · INN

bethanidine sulfate

bethanidine sulfate (TENATHAN) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bethanidine sulfate
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

bethanidine sulfate (TENATHAN) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN bethanidine sulfate
Brand TENATHAN
Mechanism Norepinephrine transporter substrate
Target Sodium-dependent noradrenaline transporter
Route ORAL
Formulation TABLET

Mechanism of action

Norepinephrine transporter substrate

Primary target: Sodium-dependent noradrenaline transporter

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amitriptyline hydrochloride Norepinephrine transporter inhibitor
  2. atomoxetine hydrochloride Norepinephrine transporter inhibitor
  3. desipramine hydrochloride Norepinephrine transporter inhibitor
  4. desvenlafaxine fumarate Norepinephrine transporter inhibitor
  5. doxepin hydrochloride Norepinephrine transporter inhibitor
  6. duloxetine hydrochloride Norepinephrine transporter inhibitor

Frequently asked questions

What is bethanidine sulfate?

bethanidine sulfate (TENATHAN) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for bethanidine sulfate?

TENATHAN is a marketed brand name for bethanidine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bethanidine sulfate?

bethanidine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.